IP Library Granted Patent US 7,208,011
Granted Patent B2
US 7,208,011 · App. 10/253,020 · Granted Apr 24, 2007

Implantable medical device with drug filled holes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,011
App. No.
10/253,020
Granted
Apr 24, 2007
Kind
B2
Abstract

The present invention relates to implantable medical devices for delivery of therapeutic agents, such as drugs, to a patient. More particularly, the invention relates to a device having therapeutic agents protected by a protective layer that prevents or retards processes that deactivate or degrade the active agents.

Claims (29)

1. An implantable medical device comprising:

an implantable device body having a plurality of through holes therein;

a barrier formed in the plurality of through holes, the barrier formed of a biodegradable copolymer having a first copolymer ratio;

a drug filled portion formed in the plurality of through holes adjacent the barrier; and

a cap formed in the plurality of through holes adjacent the drug filled portion, the cap formed of the biodegradable copolymer having a second copolymer ratio, wherein the second copolymer ratio is different from the first copolymer ratio, and wherein the barrier is formed adjacent a luminal surface of the implantable device body, the cap is formed adjacent a mural surface of the implantable device body, and the cap degrades faster than the barrier.

2. The device of claim 1 , wherein the implantable medical device is a stent.

3. The device of claim 2 , wherein the drug filled portion comprises a drug for prevention of restenosis.

4. The device of claim 1 , wherein the barrier, the drug filled portion, and the cap are formed by loading compositions dropwise into the through holes.

5. The device of claim 1 , wherein the biodegradable copolymer is poly(lactide-co-glycolide).

6. The device of claim 5 , wherein the first copolymer ratio is 85:15.

7. The device of claim 5 , wherein the second copolymer ratio is 50:50.

8. The device of claim 1 , wherein the first and second copolymer ratios are selected such that following implantation the cap degrades faster than the barrier.

9. The device of claim 1 , wherein the drug filled portion includes a limus drug.

10. The device of claim 1 , wherein the drug filled portion includes a water sensitive drug.

11. A method of forming an implantable medical device comprising:

forming an implantable device body having a plurality of through holes therein;

loading a mixture of a biodegradable copolymer having a first copolymer ratio and a first solvent into the holes and evaporating the first solvent to form a barrier;

loading a mixture of a drug, a polymer, and a second solvent into the holes and evaporating the second solvent to form a drug portion; and

loading a mixture of the biodegradable copolymer having a second copolymer ratio and a third solvent into the holes and evaporating the third solvent to form a cap, wherein the second copolymer ratio is different from the first copolymer ratio, and wherein the barrier is formed adjacent a luminal surface of the implantable device body, the cap is formed adjacent a mural surface of the implantable device body, and the cap degrades faster than the barrier.

12. The method of claim 11 , wherein the first, second, and third solvents are the same.

13. The method of claim 11 , wherein the implantable medical device is a stent.

14. The method of claim 11 , wherein the drug comprises a drug for prevention of restenosis.

15. The method of claim 11 , wherein the loading steps include loading the mixtures dropwise into the through holes.

16. The method of claim 11 , wherein the biodegradable copolymer is poly(lactide-co-glycolide).

17. The method of claim 16 , wherein the first copolymer ratio is 85:15.

18. The method of claim 16 , wherein the second copolymer ratio is 50:50.

19. The method of claim 11 , wherein the first and second copolymer ratios are selected such that following implantation the cap degrades faster than the barrier.

20. The method of claim 11 , wherein the drug comprises a limus drug.

21. The method of claim 11 , wherein the drug comprises a water sensitive drug.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2002
From: SHANLEY, JOHN F.; PARKER, THEODORE L.
To: CONOR MEDSYSTEMS, INC.
Reel/Frame 013555/0207 →